"Wentworth-Douglass Hospital is a nationally recognized, not-for-profit charitable health care organization located in the Seacoast community of Dover, New Hampshire. With a 110+ year history of compassionate care and innovation, we are proud to offer high-quality and cost-effective care to meet the needs of you and your family. Experience healthcare with heart at Wentworth-Douglass."

During the past decade, Wentworth-Douglass Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 23 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 18 clinical trials were completed. i.e. 1800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wentworth-Douglass Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "NRG Oncology" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Dana-Farber Cancer Institute" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wentworth-Douglass Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Wentworth-Douglass Hospital" are "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7" (3 trials) and "Stage IIB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "Wentworth-Douglass Hospital" in a lesser frequency.

Most popular intervention types in "Wentworth-Douglass Hospital" are "Drug" (29 trials), "Other" (29 trials), "Radiation" (15 trials), "Biological" (11 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "Quality-of-Life Assessment" (16 trials), "Carboplatin" (9 trials), "Paclitaxel" (9 trials) and "Cisplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Wentworth-Douglass Hospital" are 23 trials for "All" genders, 13 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Wentworth-Douglass Hospital". undefined are not yet recruiting, 4 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Wentworth-Douglass Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wentworth-Douglass Hospital, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Wentworth-Douglass Hospital has several departments that took part in Clinical trials: "Seacoast Cancer Center at Wentworth-Douglass Hospital" - 13 trials, "Endocrinology & Diabetes Consultants" - 4 trials, "Seacoast Arthritis And Osteoporosis Center" - 2 trials